Nuclear Medicine

Postal address
Laarbeeklaan 101
1090
Jette
Belgium

Supporting clinical sciences

Postal address
Laarbeeklaan 101
1090
Brussels
Belgium

Expertise

Development of radiopharmaceuticals for PET and radionuclide therapy applications based on camelid single domain antibody fragments (also called VHH or Nanobodies).

Optimization of (automated) radiolabeling procedures, purification methods and formulation. In vitro and in vivo evaluation of new radiopharmaceutical probes in terms of biodistribution, in vivo stability and targeting potential. Translation of preclinically validated tracers to early phase clinical trials, including fulfilling all regulatory requirements.

GMP manufacturing of radiopharmaceuticals.

Activities

  1. Immuno-PET imaging using the hPD-L1 Nanobody: Radiolabelling strategies

    Activity: Talk or presentationTalk or presentation at a conference

  2. Site-specific radiolabelled human PD-L1 Nanobody: a new tool for PET imaging

    Activity: Talk or presentationTalk or presentation at a conference

  3. Preclinical development with Nanobodies with a focus on ovarian cancer

    Activity: Talk or presentationTalk or presentation at a conference

View all (33) »

ID: 157891